Artemis Medicare Services Ltd
P&L
Quarterly Consolidated
vs Q2 FY26
Artemis Medicare Services Ltd Reports 17.2% Increase in Q3 Revenue from Operations and 7.9% Rise in Net Profit
02 Feb 2026 · 2 Feb, 7:22 pm
Summary
Artemis Medicare Services Ltd reported a 17.2% increase in Q3 revenue from operations and a 7.9% rise in net profit. The company's EBITDA also increased by 12.5%. The hospital in Gurgaon saw a 20.2% increase in revenue from operations and a 1.8% increase in profit after tax (PAT). The average revenue per occupied bed (ARPOB) was Rs 84,100, and the average length of stay (ALOS) was 3.6 days. The hospital's bed capacity utilisation stood at 62.0%. The consolidated performance showed a 17.2% increase in revenue from operations, a 12.5% increase in EBITDA, and a 7.9% increase in PAT. The 9M performance showed a 15.1% increase in revenue from operations, a 15.8% increase in EBITDA, and a 23.9% increase in PAT.
Key Highlights
- 1
17.2% increase in Q3 revenue from operations
- 2
7.9% rise in net profit
- 3
12.5% increase in EBITDA
- 4
20.2% increase in revenue from operations at Artemis Hospital Gurgaon
- 5
1.8% increase in PAT at Artemis Hospital Gurgaon
- 6
ARPOB at Rs 84,100
- 7
ALOS at 3.6 days
- 8
62.0% bed capacity utilisation
- 9
17.2% increase in consolidated revenue from operations
- 10
12.5% increase in consolidated EBITDA
- 11
7.9% increase in consolidated PAT
- 12
15.1% increase in 9M revenue from operations
- 13
15.8% increase in 9M EBITDA
- 14
23.9% increase in 9M PAT
- 15
34.9% increase in revenue from overseas patients
- 16
32% contribution of overseas patients to net revenue
Management Comments
Onkar Kanwar
Chairman, Artemis Medicare Services Ltd
We are encouraged by our continued progress during the quarter, reflecting the sustained momentum achieved in FY26. In Q3, we recorded steady growth and strong operational performance, enabled by focused execution, effective cost management, and a continued emphasis on clinical quality and patient experience. Margins and profitability remained robust, supported by a favourable case and payor mix, increased international patient inflows, and ongoing efficiency initiatives. ARPOB stayed at healthy levels throughout the quarter, highlighting our leadership in high-acuity treatments and Medical Value Travel. With respect to capacity expansion, the development of our Raipur facility is advancing as planned, with operations scheduled to commence in April 2026. As we move forward, our strategic focus remains on delivering sustainable, long-term growth through operational excellence, network expansion, and selective partnerships, while further strengthening Artemis’ reputation as a trusted and progressive healthcare platform in India.
Informational and educational content only. Not investment advice.